A comparative study of peptide-based imaging agents [68Ga] Ga-PSMA-11,[68Ga] Ga-AMBA,[68Ga] Ga-NODAGA-RGD and [68Ga] Ga-DOTA-NT-20.3 in preclinical …
J Zhang-Yin, C Provost, G Cancel-Tassin… - Nuclear Medicine and …, 2020 - Elsevier
… of prostate cancer (… in prostate cancer cell lines, but not in normal prostate epithelial ones
[42]. The level of NTSR1 expression was associated with tumour differentiation [13]. In our study…
[42]. The level of NTSR1 expression was associated with tumour differentiation [13]. In our study…
Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions
RJ Hendriks, IM Van Oort, JA Schalken - Prostate cancer and prostatic …, 2017 - nature.com
… models that … studies in which a comparison was made of two well-studied commercially
available biomarkers, the blood-based Prostate Health Index (PHI) and urinary prostate cancer …
available biomarkers, the blood-based Prostate Health Index (PHI) and urinary prostate cancer …
Resistance to androgen deprivation leads to altered metabolism in human and murine prostate cancer cell and tumor models
J Sun, RA Bok, J DeLos Santos, D Upadhyay… - Metabolites, 2021 - mdpi.com
… Comparison of steady-state metabolite … prostate cancer (PCa). However, almost all patients
eventually stop responding to ADT and develop castration-resistant prostate cancer (CRPC) […
eventually stop responding to ADT and develop castration-resistant prostate cancer (CRPC) […
Comparative analysis of primary prostate cancer treatment and subsequent metastatic disease
Objective To compare the association between previous local treatment modalities and the
progression to castrate-resistant prostate cancer (CRCP) and overall survival (OS) in men …
progression to castrate-resistant prostate cancer (CRCP) and overall survival (OS) in men …
[HTML][HTML] Head-to-head comparison of conventional, and image-and biomarker-based prostate cancer risk calculators
… study performed a head-to-head comparison of RCs incorporating mpMRI into the data from
a prospective clinical trial in … (A) ROC curve analysis for the performance of each model to …
a prospective clinical trial in … (A) ROC curve analysis for the performance of each model to …
[HTML][HTML] Comparison of radiobiological models for radiation therapy plans of prostate cancer: Three-dimensional conformal versus intensity modulated radiation …
… This study investigated the use of different radiobiological models for comparison of 3D-CRT
and IMRT plans of prostate cancer. Our results demonstrated that IMRT plans produce …
and IMRT plans of prostate cancer. Our results demonstrated that IMRT plans produce …
Systematic trial for evaluating docetaxel in a human prostate cancer cell DU145 xenograft model
M Mabuchi, M Ueda, Y Yoshida, K Horiike… - … Research, 2017 - ar.iiarjournals.org
… of hormone-refractory prostate cancer (3). Therefore, combination and comparison studies
in vitro and in vivo with DTX are vital for developing novel anti-prostate cancer agents. …
in vitro and in vivo with DTX are vital for developing novel anti-prostate cancer agents. …
Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study
… years for prostate cancer (65‐… cancer at younger ages but with prostate cancer at older ages
(both p LMICS‐vs‐HICs < 0.001). In countries with higher smoking prevalence, lung cancers …
(both p LMICS‐vs‐HICs < 0.001). In countries with higher smoking prevalence, lung cancers …
Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: a construct validation …
J Ebbing, F Jäderling, JW Collins, O Akre, S Carlsson… - PLoS …, 2018 - journals.plos.org
… Each prostate model contained a single prostate cancer lesion (pink colour). Tumor
characteristics for case 1 were cT2, PI-RADS 5 (size 15x9x21 mm), mriT3, pT3a, Gleason 4+3 (…
characteristics for case 1 were cT2, PI-RADS 5 (size 15x9x21 mm), mriT3, pT3a, Gleason 4+3 (…
Prediction models for prostate cancer to be used in the primary care setting: a systematic review
… . Head-To-Head comparison of prostate cancer risk calculators predicting biopsy outcome.
Transl Androl Urol 2018;7:18–26.doi:10.21037/tau.2017.12.21pmid:http://www.ncbi.nlm.nih.…
Transl Androl Urol 2018;7:18–26.doi:10.21037/tau.2017.12.21pmid:http://www.ncbi.nlm.nih.…